OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). 03/01/2020 - 08/15/2022. N01DA-19-2250.T

NIH RePORTER · NIH · N01 · $1,772,024 · view on reporter.nih.gov ↗

Abstract

OPTIMIZING RETENTION, DURATION&DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100).

Key facts

NIH application ID
10290928
Project number
75N95019D00013-0-759502000002-1
Recipient
THE EMMES COMPANY, LLC
Principal Investigator
PAUL VANVELDHUISEN
Activity code
N01
Funding institute
NIH
Fiscal year
2020
Award amount
$1,772,024
Award type
—
Project period
2020-03-01 → 2022-08-15